Clinical Trials Directory

Trials / Completed

CompletedNCT03399994

Clinical Trial of Abluminus DES+ Sirolimus Eluting Stent Versus Everolimus-eluting DES

A Randomized Clinical Trial of Abluminus DES+ Sirolimus Eluting Stent Versus Everolimus-eluting DES for Percutaneous Coronary Intervention in Patients With Diabetes Mellitus: an Investigator-initiated Pilot Study

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
137 (actual)
Sponsor
Fondazione Evidence per Attività e Ricerche Cardiovascolari ONLUS · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

The objective of the study is to compare angiographic and clinical performance of Abluminus DES+ versus Everolimus-eluting DES in patients with diabetes mellitus.

Detailed description

The present clinical investigation is designed as a prospective, multicentre, national, randomized, open label, 2-arm parallel group, pilot trial comparing Abluminus DES+ versus Everolimus-eluting DES on Late Lumen Loss and clinical outcomes in diabetic patients undergoing Percutaneous Coronary Intervention. A total of 165 patients will be recruited and randomized in the two groups in a 2:1 ratio at up to 6-8 Italian sites. After index procedure, patients will be followed up by angiographic follow-up at 9 months and clinical follow-up at 12 months. The study design is open label, since it is not possible to blind the investigators as to the stent type. However the members of the Event Adjudication Committee will be blinded to the patient. assignment. All medical records, source documentation and event information collected for the adjudication process will be blinded to treatment assignment. In addition the primary endpoint will be independently evaluated by the Core-Lab which will be blinded as to group assignment.

Conditions

Interventions

TypeNameDescription
DEVICEdevice implantation during coronary angioplastydevice implantation during coronary angioplasty

Timeline

Start date
2018-05-21
Primary completion
2021-04-15
Completion
2022-07-26
First posted
2018-01-17
Last updated
2022-07-27

Locations

6 sites across 1 country: Italy

Source: ClinicalTrials.gov record NCT03399994. Inclusion in this directory is not an endorsement.